학술논문
CD14 positive cells accelerate hematopoietic stem cell engraftment
Document Type
Article
Author
Source
Bone Marrow Transplantation; June 2022, Vol. 57 Issue: 6 p942-948, 7p
Subject
Language
ISSN
02683369; 14765365
Abstract
The improvement of hematopoietic stem and progenitor cell (HSPC) engraftment remains a high-priority goal when limited cell doses are available, such as in cord blood (CB) transplantation and HSC gene therapy. We observed that monocytes are highly effective at improving the engraftment of both CB-CD34+and lentivirus-transfected CD34+cells in a xenogeneic model of HSC transplantation. Moreover, monocytes, in particular the CD14+CD16−classical subset, in co-culture systems increase survival and stemness of CB-CD34+cells. Both soluble factors and direct-cell contact interactions, such as JAG/NOTCH and COX-2/PGE2 pathways, are critically involved in the HSC-monocyte crosstalk. Our results indicate that the infusion of monocytes improves engraftment when cell dose is a limiting factor.